Vertex (VRTX) holder files to sell 1,751 shares after prior sale

Rhea-AI Filing Summary

Edward Atkinson, a holder of Vertex Pharmaceuticals (VRTX) common stock, has filed a notice of proposed sale of 1,751 common shares through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $806,212.93.

The 1,751 common shares were acquired on 02/10/2026 via restricted stock vesting from the issuer as compensation. The notice also reports that Atkinson sold 2,500 common shares on 11/17/2025 for gross proceeds of $1,086,450.00. Vertex had 253,718,831 common shares outstanding at the time referenced.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1751	806212.93	253718831	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			1751	02/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Edward Atkinson 50 Northern Avenue Boston MA 02210	Common	11/17/2025	2500	1086450.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What stock sale is disclosed for Vertex (VRTX) in this Form 144?

Edward Atkinson plans to sell 1,751 Vertex common shares. The planned sale will be executed through Fidelity Brokerage Services on NASDAQ, with the filing citing an aggregate market value of $806,212.93 for these shares at the time of the notice.

How did Edward Atkinson acquire the 1,751 Vertex (VRTX) shares to be sold?

The 1,751 common shares were acquired via restricted stock vesting. According to the notice, Atkinson received the shares on 02/10/2026 from the issuer as compensation, and the same date is listed as the payment date for this equity-based award.

What prior Vertex (VRTX) stock sales by Edward Atkinson are reported?

The notice reports a prior sale of 2,500 common shares. That earlier transaction occurred on 11/17/2025 and generated gross proceeds of $1,086,450.00, providing context on recent selling activity by the same shareholder.

How many Vertex (VRTX) shares were outstanding at the time of the filing?

The notice lists 253,718,831 common shares outstanding. This figure gives a sense of the company’s equity base relative to the 1,751-share proposed sale, which represents a very small portion of the total outstanding common stock.

Through which broker and exchange will the Vertex (VRTX) shares be sold?

The planned sale will use Fidelity Brokerage Services LLC on NASDAQ. The notice specifies Fidelity’s Smithfield, Rhode Island address and identifies NASDAQ as the securities exchange where the 1,751 Vertex common shares are expected to be sold.